Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2013-04-30
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Neuromuscular Blocking Agents and Their Antagonism
NCT06238219
Neuromuscular Blocking Agents in the Elderly
NCT03857750
Neuromuscular Blocking Agents in Cardiac Surgery
NCT06595277
Incidence and Severity of Residual Neuromuscular Blockade
NCT02660398
Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety
NCT04124757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
neuromuscular block
rocuronium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rocuronium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients scheduled for general anaesthesia with endotracheal intubation
Exclusion Criteria
* scheduled for awake fiberoptic intubation
* pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kreiskrankenhaus Dormagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan Soltesz, MD
Role: PRINCIPAL_INVESTIGATOR
KKH Dormagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KKH Dormagen
Dormagen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
diffmask
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.